查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2037246

2026-2034年全球去端肽膠原市場規模、佔有率、趨勢和成長分析報告

Global Atelocollagen Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球去端肽膠原蛋白市場預計將從2025年的95.8億美元成長至2034年的167億美元，2026年至2034年的複合年成長率（CAGR）為6.37%。該市場成長勢頭強勁，主要得益於其在醫療、美容和製藥行業的應用不斷拓展。去端肽膠原蛋白以其良好的生物相容性和低免疫抗原性而著稱，廣泛應用於組織工程、藥物傳輸系統和美容手術。對微創治療和再生醫學日益成長的需求是推動市場成長的主要因素。此外，生物技術的進步也提高了去端肽膠原蛋白產品的品質和供應量。

人口老化以及對活膚和抗衰老等美容用途的需求不斷成長是推動市場成長的主要因素。此外，由於其促進組織再生的能力，去端肽膠原蛋白在醫療領域，例如創傷治療和整形外科治療中，應用日益廣泛。研發活動正在拓展其應用範圍，進一步增強了市場前景。發展中地區醫療基礎設施投資的增加也為市場成長提供了支持。

阿特洛膠原蛋白市場潛力巨大，生物材料和再生醫學領域預計將持續創新。各公司預計將專注於開發先進配方，以提高療效和安全性。個人化醫療和標靶治療的擴展將為阿特洛膠原蛋白的應用創造新的機會。隨著對生物相容性材料需求的持續成長，預計未來幾年該市場將保持穩定成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業的市場定位、產品系列、策略舉措和財務表現進行了詳細評估。這為深入了解競爭動態和主要參與者所採取的策略提供了寶貴的見解。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點，或針對特定細分市場的深入洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球去端肽膠原蛋白市場：依來源分類

  • 市場分析、洞察與預測
  • 牛膠原蛋白
  • 豬源膠原膠原蛋白
  • 其他

第5章：全球去端肽膠原蛋白市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術產業
  • 化妝品產業
  • 醫療設備業
  • 其他

第6章：全球去端肽膠原蛋白市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Integra LifeSciences Corporation
    • Innocoll Holdings Limited
    • Koken Co. Ltd
    • DSM
    • Collagen Matrix Inc
    • EnColl
    • Collagen Solutions Plc
    • VIVACY
    • Kybella
    • Roche
    • Medytox
    • Genomatica
    • Evolus
    • Hyaluronic Acid Co
簡介目錄
Product Code: VMR11212690

The global atelocollagen market size is expected to reach USD 16.70 Billion in 2034 from USD 9.58 Billion in 2025, growing at a CAGR of 6.37 during 2026-2034.This market is gaining momentum due to its increasing applications in medical, cosmetic, and pharmaceutical industries. Atelocollagen, known for its biocompatibility and low immunogenicity, is widely used in tissue engineering, drug delivery systems, and aesthetic procedures. The rising demand for minimally invasive treatments and regenerative medicine is significantly contributing to market growth. Additionally, advancements in biotechnology are enhancing the quality and availability of atelocollagen-based products.

Key drivers include the growing aging population and increasing demand for cosmetic enhancements such as skin rejuvenation and anti-aging treatments. The healthcare sector is also adopting atelocollagen for wound healing and orthopedic applications due to its ability to support tissue regeneration. Research and development activities are expanding the scope of its applications, further strengthening market prospects. Increased investment in healthcare infrastructure across developing regions is also supporting growth.

Future prospects of the atelocollagen market are highly promising, with continuous innovation expected in biomaterials and regenerative therapies. Companies are likely to focus on developing advanced formulations to improve efficacy and safety. The expansion of personalized medicine and targeted therapies will create new opportunities for atelocollagen usage. As demand for biocompatible materials continues to rise, the market is expected to experience sustained growth in the coming years.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Source

  • Bovine Collagen
  • Porcine Collagen
  • Others

By End-Users

  • Pharmaceutical & Biotechnology Industries
  • Cosmetic Industries
  • Medical Devices Industries
  • Others

COMPANIES PROFILED

  • Integra LifeSciences Corporation, Innocoll Holdings Limited, Koken Co. Ltd., DSM, Collagen Matrix Inc., EnColl, Collagen Solutions Plc., VIVACY, Kybella, Roche, Medytox, Genomatica, Evolus, Hyaluronic Acid Co

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ATELOCOLLAGEN MARKET: BY SOURCE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Source
  • 4.2. Bovine Collagen Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Porcine Collagen Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ATELOCOLLAGEN MARKET: BY END-USERS 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-users
  • 5.2. Pharmaceutical & Biotechnology Industries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cosmetic Industries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Medical Devices Industries Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ATELOCOLLAGEN MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Source
    • 6.2.2 By End-users
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Source
    • 6.3.2 By End-users
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Source
    • 6.4.2 By End-users
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Source
    • 6.5.2 By End-users
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Source
    • 6.6.2 By End-users
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ATELOCOLLAGEN INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Integra LifeSciences Corporation
    • 8.2.2 Innocoll Holdings Limited
    • 8.2.3 Koken Co. Ltd
    • 8.2.4 DSM
    • 8.2.5 Collagen Matrix Inc
    • 8.2.6 EnColl
    • 8.2.7 Collagen Solutions Plc
    • 8.2.8 VIVACY
    • 8.2.9 Kybella
    • 8.2.10 Roche
    • 8.2.11 Medytox
    • 8.2.12 Genomatica
    • 8.2.13 Evolus
    • 8.2.14 Hyaluronic Acid Co